nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—Levomethadyl Acetate—CYP19A1—esophageal cancer	0.0058	0.232	CrCbGaD
Propiomazine—Methadone—CYP19A1—esophageal cancer	0.0034	0.136	CrCbGaD
Propiomazine—Diltiazem—ABCB1—esophageal cancer	0.00243	0.0974	CrCbGaD
Propiomazine—Triflupromazine—ABCB1—esophageal cancer	0.00217	0.0868	CrCbGaD
Propiomazine—Fluphenazine—ABCB1—esophageal cancer	0.00167	0.0668	CrCbGaD
Propiomazine—Clomipramine—ABCB1—esophageal cancer	0.00152	0.0611	CrCbGaD
Propiomazine—Chlorprothixene—ABCB1—esophageal cancer	0.00152	0.0608	CrCbGaD
Propiomazine—Trimipramine—ABCB1—esophageal cancer	0.0014	0.0562	CrCbGaD
Propiomazine—Promethazine—ABCB1—esophageal cancer	0.00135	0.0541	CrCbGaD
Propiomazine—Trifluoperazine—ABCB1—esophageal cancer	0.00133	0.0534	CrCbGaD
Propiomazine—Methadone—ABCB1—esophageal cancer	0.00133	0.0533	CrCbGaD
Propiomazine—Chlorpromazine—ABCB1—esophageal cancer	0.00105	0.0419	CrCbGaD
Propiomazine—HRH1—Signaling Pathways—NOTCH2—esophageal cancer	0.000205	0.000211	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000205	0.00021	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000205	0.00021	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000204	0.000209	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—KDR—esophageal cancer	0.000202	0.000207	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.000202	0.000207	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000202	0.000207	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000201	0.000206	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	0.0002	0.000205	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—KDR—esophageal cancer	0.0002	0.000205	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—SMAD4—esophageal cancer	0.000199	0.000204	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—KDR—esophageal cancer	0.000191	0.000196	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	0.000191	0.000195	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NOTCH1—esophageal cancer	0.000191	0.000195	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HIF1A—esophageal cancer	0.00019	0.000195	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	0.000188	0.000193	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	0.000188	0.000193	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TGFBR2—esophageal cancer	0.000186	0.00019	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000183	0.000187	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TGFBR2—esophageal cancer	0.000182	0.000187	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—KDR—esophageal cancer	0.000182	0.000187	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000182	0.000186	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	0.000181	0.000186	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	0.00018	0.000185	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—KDR—esophageal cancer	0.00018	0.000184	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	0.000179	0.000184	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000179	0.000183	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—SMAD4—esophageal cancer	0.000176	0.00018	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—SMAD4—esophageal cancer	0.000173	0.000177	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CREBBP—esophageal cancer	0.000173	0.000177	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—SMAD4—esophageal cancer	0.000172	0.000177	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	0.000172	0.000176	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NOTCH1—esophageal cancer	0.000172	0.000176	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	0.000171	0.000176	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	0.00017	0.000175	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—EGFR—esophageal cancer	0.00017	0.000174	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	0.00017	0.000174	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	0.000169	0.000174	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	0.000169	0.000174	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	0.000167	0.000172	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	0.000163	0.000167	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	0.000163	0.000167	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000162	0.000166	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	0.00016	0.000164	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00016	0.000164	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	0.000156	0.00016	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—KDR—esophageal cancer	0.000156	0.00016	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CREBBP—esophageal cancer	0.000156	0.00016	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—NOS3—esophageal cancer	0.000155	0.000159	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	0.000153	0.000157	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000153	0.000157	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—EGFR—esophageal cancer	0.000153	0.000157	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—NOS3—esophageal cancer	0.000153	0.000157	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	0.000151	0.000155	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—KDR—esophageal cancer	0.000149	0.000153	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—PIK3CA—esophageal cancer	0.000147	0.000151	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	0.000147	0.000151	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—NOS3—esophageal cancer	0.000146	0.00015	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000146	0.00015	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	0.000145	0.000149	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—ERBB2—esophageal cancer	0.000145	0.000148	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000144	0.000148	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HIF1A—esophageal cancer	0.000144	0.000147	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	0.000143	0.000146	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—HIF1A—esophageal cancer	0.000141	0.000145	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HIF1A—esophageal cancer	0.000141	0.000145	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	0.000141	0.000144	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	0.00014	0.000144	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	0.00014	0.000144	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—NOS3—esophageal cancer	0.000139	0.000143	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	0.000139	0.000143	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	0.000139	0.000142	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	0.000138	0.000142	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—KDR—esophageal cancer	0.000137	0.000141	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	0.000137	0.000141	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—CREBBP—esophageal cancer	0.000137	0.000141	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	0.000137	0.00014	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—KDR—esophageal cancer	0.000135	0.000139	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—KDR—esophageal cancer	0.000135	0.000138	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—KDR—esophageal cancer	0.000135	0.000138	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—KDR—esophageal cancer	0.000134	0.000138	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	0.000133	0.000136	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—KDR—esophageal cancer	0.000133	0.000136	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000133	0.000136	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—KDR—esophageal cancer	0.000132	0.000136	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	0.000131	0.000134	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	0.000131	0.000134	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—ERBB2—esophageal cancer	0.00013	0.000134	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NOTCH1—esophageal cancer	0.00013	0.000133	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	0.000129	0.000132	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CCND1—esophageal cancer	0.000128	0.000131	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NOTCH1—esophageal cancer	0.000127	0.000131	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	0.000127	0.000131	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	0.000127	0.00013	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	0.000127	0.00013	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	0.000126	0.00013	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CCND1—esophageal cancer	0.000126	0.000129	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	0.000125	0.000128	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	0.000125	0.000128	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000125	0.000128	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000125	0.000128	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—CDKN1A—esophageal cancer	0.000124	0.000127	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—NOS3—esophageal cancer	0.000123	0.000126	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	0.000122	0.000125	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CCND1—esophageal cancer	0.000121	0.000124	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00012	0.000123	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—NOS3—esophageal cancer	0.000119	0.000122	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EP300—esophageal cancer	0.000118	0.000121	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CREBBP—esophageal cancer	0.000117	0.00012	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	0.000117	0.00012	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EP300—esophageal cancer	0.000116	0.000119	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	0.000116	0.000118	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—EGFR—esophageal cancer	0.000115	0.000118	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	0.000115	0.000118	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CCND1—esophageal cancer	0.000115	0.000118	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	0.000115	0.000118	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	0.000115	0.000117	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	0.000114	0.000117	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	0.000114	0.000116	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	0.000114	0.000116	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	0.000113	0.000116	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	0.000113	0.000116	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	0.000113	0.000116	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	0.000113	0.000116	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	0.000113	0.000116	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	0.000113	0.000115	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PTGS2—esophageal cancer	0.000112	0.000115	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	0.000111	0.000114	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	0.000111	0.000114	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—CDKN1A—esophageal cancer	0.000111	0.000114	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	0.000111	0.000114	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EP300—esophageal cancer	0.000111	0.000114	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00011	0.000113	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	0.00011	0.000113	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000109	0.000111	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000109	0.000111	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000108	0.000111	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000108	0.000111	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000108	0.00011	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	0.000107	0.000109	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000107	0.000109	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000106	0.000109	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EP300—esophageal cancer	0.000106	0.000109	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—NOS3—esophageal cancer	0.000105	0.000108	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EP300—esophageal cancer	0.000105	0.000107	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—NOS3—esophageal cancer	0.000103	0.000106	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—NOS3—esophageal cancer	0.000103	0.000106	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	0.000103	0.000106	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	0.000103	0.000105	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—MYC—esophageal cancer	0.000103	0.000105	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	0.000102	0.000104	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	0.000101	0.000104	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—MYC—esophageal cancer	0.000101	0.000104	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—EGFR—esophageal cancer	0.0001	0.000103	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	0.0001	0.000103	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	9.89e-05	0.000101	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	9.85e-05	0.000101	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CCND1—esophageal cancer	9.84e-05	0.000101	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—ERBB2—esophageal cancer	9.83e-05	0.000101	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	9.83e-05	0.000101	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	9.8e-05	0.000101	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	9.77e-05	0.0001	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—MYC—esophageal cancer	9.69e-05	9.93e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	9.68e-05	9.92e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	9.67e-05	9.92e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	9.65e-05	9.9e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	9.65e-05	9.9e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	9.62e-05	9.87e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	9.59e-05	9.84e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	9.52e-05	9.77e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	9.5e-05	9.74e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—EGFR—esophageal cancer	9.47e-05	9.72e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	9.47e-05	9.72e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	9.42e-05	9.66e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—EP300—esophageal cancer	9.33e-05	9.57e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—MYC—esophageal cancer	9.23e-05	9.47e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	9.12e-05	9.35e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—MYC—esophageal cancer	9.11e-05	9.34e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EP300—esophageal cancer	9.06e-05	9.29e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—EGFR—esophageal cancer	9.03e-05	9.26e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	8.91e-05	9.14e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—PIK3CA—esophageal cancer	8.7e-05	8.93e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CCND1—esophageal cancer	8.69e-05	8.91e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EP300—esophageal cancer	8.67e-05	8.9e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	8.59e-05	8.81e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CCND1—esophageal cancer	8.55e-05	8.77e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CCND1—esophageal cancer	8.53e-05	8.75e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	8.5e-05	8.72e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	8.48e-05	8.69e-05	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—TP53—esophageal cancer	8.42e-05	8.64e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	8.4e-05	8.62e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	8.39e-05	8.61e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	8.37e-05	8.58e-05	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—TP53—esophageal cancer	8.31e-05	8.52e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	8.27e-05	8.48e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	8.25e-05	8.46e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	8.23e-05	8.44e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	8.22e-05	8.43e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	8.2e-05	8.41e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	8.12e-05	8.33e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	8.1e-05	8.3e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EP300—esophageal cancer	8e-05	8.2e-05	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—TP53—esophageal cancer	7.95e-05	8.16e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—MYC—esophageal cancer	7.9e-05	8.1e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EP300—esophageal cancer	7.87e-05	8.07e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EP300—esophageal cancer	7.85e-05	8.05e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—PIK3CA—esophageal cancer	7.84e-05	8.04e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EP300—esophageal cancer	7.83e-05	8.03e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EP300—esophageal cancer	7.8e-05	8e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	7.73e-05	7.93e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EP300—esophageal cancer	7.73e-05	7.92e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—EGFR—esophageal cancer	7.72e-05	7.92e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EP300—esophageal cancer	7.7e-05	7.9e-05	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—TP53—esophageal cancer	7.58e-05	7.77e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—MYC—esophageal cancer	7.56e-05	7.75e-05	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—TP53—esophageal cancer	7.48e-05	7.67e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	7.39e-05	7.58e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—MYC—esophageal cancer	6.97e-05	7.15e-05	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—PIK3CA—esophageal cancer	6.9e-05	7.08e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—MYC—esophageal cancer	6.86e-05	7.03e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—MYC—esophageal cancer	6.84e-05	7.02e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—MYC—esophageal cancer	6.82e-05	6.99e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—EGFR—esophageal cancer	6.82e-05	6.99e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—MYC—esophageal cancer	6.8e-05	6.97e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—MYC—esophageal cancer	6.73e-05	6.9e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—MYC—esophageal cancer	6.71e-05	6.89e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—EGFR—esophageal cancer	6.71e-05	6.88e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	6.7e-05	6.87e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—EGFR—esophageal cancer	6.69e-05	6.86e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	6.67e-05	6.84e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	6.65e-05	6.82e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	6.58e-05	6.75e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	6.57e-05	6.74e-05	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—TP53—esophageal cancer	6.48e-05	6.65e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	6.42e-05	6.58e-05	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—TP53—esophageal cancer	6.21e-05	6.37e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	5.92e-05	6.07e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	5.82e-05	5.97e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	5.81e-05	5.96e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.79e-05	5.94e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	5.77e-05	5.92e-05	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—TP53—esophageal cancer	5.72e-05	5.87e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	5.72e-05	5.86e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	5.7e-05	5.85e-05	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—TP53—esophageal cancer	5.63e-05	5.78e-05	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—TP53—esophageal cancer	5.62e-05	5.76e-05	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—TP53—esophageal cancer	5.6e-05	5.74e-05	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—TP53—esophageal cancer	5.58e-05	5.73e-05	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—TP53—esophageal cancer	5.53e-05	5.67e-05	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—TP53—esophageal cancer	5.51e-05	5.65e-05	CbGpPWpGaD
